metronidazole has been researched along with Urinary Tract Infections in 70 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The characteristics and outcomes of patients infected with ESBL-ENT were examined in a pooled analysis of Phase 3 clinical trials of ceftolozane/tazobactam in patients with complicated urinary tract infections (ASPECT-cUTI) and complicated intra-abdominal infections (ASPECT-cIAI)." | 9.24 | Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. ( Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O, 2017) |
| "A controlled, randomized trial with blind assessment of end points is described comparing ceftriaxone (1 g) given at induction of anesthesia with gentamicin (2 mg/kg) and metronidazole (500 mg) (GM), three times, every eight hours starting at induction, in preventing wound, chest, and urinary tract infections following bowel operations." | 9.07 | Ceftriaxone is more effective than gentamicin/metronidazole prophylaxis in reducing wound and urinary tract infections after bowel operations. Results of a controlled, randomized, blind clinical trial. ( Morris, WT, 1993) |
| " Ceftolozane/tazobactam is an antibacterial with potent activity against Gram-negative pathogens and is approved for the treatment of cIAI (with metronidazole) and cUTI (including pyelonephritis)." | 5.24 | Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam. ( Huntington, JA; Long, J; Popejoy, MW, 2017) |
| " The characteristics and outcomes of patients infected with ESBL-ENT were examined in a pooled analysis of Phase 3 clinical trials of ceftolozane/tazobactam in patients with complicated urinary tract infections (ASPECT-cUTI) and complicated intra-abdominal infections (ASPECT-cIAI)." | 5.24 | Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. ( Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O, 2017) |
| "A controlled, randomized trial with blind assessment of end points is described comparing ceftriaxone (1 g) given at induction of anesthesia with gentamicin (2 mg/kg) and metronidazole (500 mg) (GM), three times, every eight hours starting at induction, in preventing wound, chest, and urinary tract infections following bowel operations." | 5.07 | Ceftriaxone is more effective than gentamicin/metronidazole prophylaxis in reducing wound and urinary tract infections after bowel operations. Results of a controlled, randomized, blind clinical trial. ( Morris, WT, 1993) |
| "An open randomized study was done to compare the prophylactic value of single doses of netilmycin-metronidazole versus trimethoprim-sulfamethoxazole in the prevention of postoperative infections associated with transrectal prostatic biopsy." | 5.07 | A randomized comparative study of the prophylactic use of trimethoprim-sulfamethoxazole versus netilmycin-metronidazole in transrectal prostatic biopsy. ( Boisseau, DA; Fong, IW; Honey, RJ; Simbul, M; Struthers, N, 1991) |
| "Metronidazole was well tolerated by the mother and with this type of administration regimen, the fetus is not exposed to the drug." | 2.67 | Prevention of postcesarean infectious morbidity with a single dose of intravenous metronidazole. ( Garcia-Rojas, JM; Lozada-Leon, JD; Ruiz-Moreno, JA, 1991) |
| "The incidence of wound infections and the duration of hospitalization were significantly reduced in patients undergoing vaginal hysterectomy with or without vaginal repair." | 2.67 | Single-dose prophylaxis in hysterectomies. An interim analysis. ( Boodt, PJ; Janknegt, R; Snijders, WP, 1990) |
| "Cefuroxime was successful, metronidazole failed in the prevention of minor morbidity." | 2.67 | Vaginal hysterectomy: cefuroxime, metronidazole or both? ( Kauer, FM; Manson, WL; Wijma, J, 1990) |
| "The incidence of post-operative wound infections and urinary tract infections were similar in both groups [wound infections in 1/75 versus 2/84 patients (NS), urinary tract infections 4/75 versus 3/84 patients (NS), respectively, in the 24-h group and single-dose group]." | 2.67 | Antibiotic prophylaxis in abdominal hysterectomy, with special reference to the duration of the prophylaxis. ( Eckenhausen, FW; Jonker, PL, 1990) |
| "Bacteremia was infrequently detected, but isolated pathogens were multidrug resistant." | 1.56 | Prevalence, Etiology, and Outcome of Sepsis among Critically Ill Patients in Malawi. ( Charles, A; Kadyaudzu, C; Onofrey, L; Prin, M; Purcell, L, 2020) |
| "None of the patients developed postoperative wound infections or adverse reactions." | 1.26 | Cefuroxime and metronidazole in gynaecological surgery. ( Kingston, J; Leabeater, B, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (55.71) | 18.7374 |
| 1990's | 11 (15.71) | 18.2507 |
| 2000's | 6 (8.57) | 29.6817 |
| 2010's | 11 (15.71) | 24.3611 |
| 2020's | 3 (4.29) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte Thibault, M | 1 |
| Milen, A | 1 |
| Burns, L | 1 |
| Tilea, A | 1 |
| Piehl, K | 1 |
| Morgan, D | 1 |
| Prin, M | 1 |
| Onofrey, L | 1 |
| Purcell, L | 1 |
| Kadyaudzu, C | 1 |
| Charles, A | 1 |
| Illiano, E | 1 |
| Trama, F | 1 |
| Crocetto, F | 1 |
| Califano, G | 1 |
| Aveta, A | 1 |
| Motta, G | 1 |
| Pastore, AL | 1 |
| Brancorsini, S | 1 |
| Fabi, C | 1 |
| Costantini, E | 1 |
| Popejoy, MW | 2 |
| Long, J | 1 |
| Huntington, JA | 2 |
| Edson, RS | 1 |
| Litin, SC | 1 |
| Bundrick, JB | 1 |
| Giraud, N | 1 |
| Ripault-Cesbron, H | 1 |
| Cottier, JP | 1 |
| Dardaine-Giraud, V | 1 |
| Kolwijck, E | 1 |
| Seegers, AEM | 1 |
| Tops, SCM | 1 |
| van der Heijden, AG | 1 |
| Sedelaar, JPM | 1 |
| Ten Oever, J | 1 |
| Ijarotimi, AO | 1 |
| Badejoko, OO | 1 |
| Ijarotimi, O | 1 |
| Loto, OM | 1 |
| Orji, EO | 2 |
| Fasubaa, OB | 1 |
| Heidari Bateni, Z | 1 |
| Shahrokh, H | 1 |
| Salimi, H | 1 |
| Safari, H | 1 |
| Tabatabai, M | 1 |
| Saedi, D | 1 |
| Paterson, DL | 1 |
| Cloutier, D | 1 |
| Miller, B | 1 |
| Bliss, CA | 1 |
| Steenbergen, JN | 1 |
| Hershberger, E | 1 |
| Umeh, O | 1 |
| Kaye, KS | 1 |
| Bommannan, K | 1 |
| Gaspar, BL | 1 |
| Sachdeva, MU | 1 |
| Alekwe, LO | 1 |
| Kuti, O | 1 |
| Ogunniyi, SO | 1 |
| Evans, D | 1 |
| Shakur, R | 1 |
| Scott, D | 1 |
| Koul, S | 1 |
| Bhan-Kotwal, S | 1 |
| Jenkins, HS | 1 |
| Carmaciu, CD | 1 |
| Gupta, P | 1 |
| Gupta, R | 2 |
| Jandial, K | 1 |
| Samotra, S | 1 |
| Rana, V | 1 |
| Gupta, S | 1 |
| Singh, J | 1 |
| Boyanova, L | 1 |
| Ilieva, J | 1 |
| Gergova, G | 1 |
| Davidkov, L | 1 |
| Spassova, Z | 1 |
| Kamburov, V | 1 |
| Katsarov, N | 1 |
| Mitov, I | 1 |
| Rajendran, R | 1 |
| Sreekumar, S | 2 |
| Sudhakar, A | 1 |
| BAUER, H | 1 |
| FEO, LG | 1 |
| FETTER, TR | 1 |
| SYLVESTRE, L | 1 |
| BELANGER, M | 1 |
| GALLAI, Z | 1 |
| DRAPER, JW | 1 |
| AKBARI, A | 1 |
| WARD, JN | 1 |
| MACGILLAVRAY, I | 1 |
| SENECA, H | 1 |
| PETRI, C | 1 |
| Yang, L | 1 |
| Hu, J | 1 |
| Wei, H | 1 |
| Wang, L | 1 |
| Zhong, H | 1 |
| Sen, A | 1 |
| Mahalanabis, D | 1 |
| Mukhopadhyay, S | 1 |
| Chakrabarty, K | 1 |
| Singh, AK | 1 |
| Bisai, S | 1 |
| Chakrabarty, M | 1 |
| Halder, D | 1 |
| Islam, MA | 1 |
| Romero Ganuza, FJ | 1 |
| Harper, JR | 1 |
| Houang, ET | 1 |
| Watson, C | 1 |
| Howell, R | 1 |
| Chapman, M | 1 |
| Wacha, H | 1 |
| Probst, M | 1 |
| Kvist Poulsen, H | 1 |
| Borel, J | 2 |
| Kauppila, A | 1 |
| Rautiainen, H | 1 |
| Tuimala, R | 1 |
| Poulsen, HK | 1 |
| Olsen, H | 1 |
| Vincelette, J | 1 |
| Finkelstein, F | 1 |
| Aoki, FY | 1 |
| Ti, TY | 1 |
| Ogilvie, RI | 1 |
| Richard, GK | 1 |
| Seymour, RJ | 1 |
| Popkin, DR | 1 |
| Martinez, LA | 1 |
| Carswell, GA | 1 |
| Gerstner, G | 1 |
| Schmid, R | 1 |
| Leabeater, B | 1 |
| Kingston, J | 1 |
| Higgins, AF | 1 |
| Lewis, A | 1 |
| Noone, P | 1 |
| Hole, ML | 1 |
| Brouwer, WK | 2 |
| Hoogkamp Korstanje, JA | 1 |
| Fraser, GM | 1 |
| Inbar-Yanai, I | 1 |
| Niv, Y | 1 |
| Morris, WT | 1 |
| Henriksson, L | 1 |
| Colling-Saltin, AS | 1 |
| Frick, G | 1 |
| Kullander, S | 1 |
| Sandholm, LE | 1 |
| Ursing, J | 1 |
| Cederberg, A | 1 |
| Chilaka, VN | 1 |
| Mayne, CJ | 1 |
| Gray, JA | 1 |
| Suriyanon, V | 1 |
| Nelson, KE | 1 |
| Choomsai na Ayudhya, V | 1 |
| Ruiz-Moreno, JA | 1 |
| Garcia-Rojas, JM | 1 |
| Lozada-Leon, JD | 1 |
| Fong, IW | 1 |
| Struthers, N | 1 |
| Honey, RJ | 1 |
| Simbul, M | 1 |
| Boisseau, DA | 1 |
| Boodt, PJ | 1 |
| Snijders, WP | 1 |
| Janknegt, R | 1 |
| Kauer, FM | 1 |
| Wijma, J | 1 |
| Manson, WL | 1 |
| Eckenhausen, FW | 1 |
| Jonker, PL | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Kuiper, KM | 1 |
| Friese, S | 2 |
| Willems, FT | 2 |
| Loriaux, SM | 2 |
| Meewis, JM | 1 |
| Mendel, V | 1 |
| Jung, D | 1 |
| Heymann, H | 1 |
| Pricker, GJ | 1 |
| Berg, AO | 1 |
| Soman, MP | 1 |
| Ledger, WJ | 1 |
| Gaudin, G | 1 |
| Thadepalli, H | 1 |
| Castelli, M | 1 |
| Barbieri, ML | 1 |
| Arletti, R | 1 |
| Bertolini, A | 1 |
| Schneider, GT | 1 |
| Geary, WL | 1 |
| Rŏigas, E | 1 |
| Teras, J | 1 |
| Kaarma, H | 1 |
| Finegold, SM | 1 |
| Rosenblatt, JE | 1 |
| Kawamura, N | 1 |
| Lal, S | 1 |
| Walker, AN | 1 |
| James, DG | 1 |
| Bailey, AR | 1 |
| Brunt, ME | 1 |
| Starck, V | 1 |
| Bruhn-Petersen, F | 1 |
| March, CH | 1 |
| Littlewood, JM | 1 |
| Kohler, HG | 1 |
| Elste, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Efficacy and Safety of Intravenous CXA-201 With That of Meropenem in Complicated Intraabdominal Infections[NCT01445678] | Phase 3 | 494 participants (Actual) | Interventional | 2011-12-23 | Completed | ||
| A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis[NCT01345929] | Phase 3 | 558 participants (Actual) | Interventional | 2011-06-20 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Clinical cure is complete resolution or significant improvement in signs and symptoms of the index infection, such that no additional antibacterial therapy or surgical or drainage procedure was required for the index infection. (NCT01445678)
Timeframe: TOC; 26-30 days after start of study drug administration
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 and Metronidazole as Treatment for cIAI | 83.0 |
| Meropenem as Treatment for cIAI | 87.3 |
Clinical response is complete resolution or significant improvement in signs and symptoms of the index infection, such that no additional antibacterial therapy or surgical or drainage procedure was required for the index infection. (NCT01445678)
Timeframe: EOT; Within 24 hours of last study drug administration
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 and Metronidazole as Treatment for cIAI | 89.2 |
| Meropenem as Treatment for cIAI | 92.3 |
Clinical response is complete resolution or significant improvement in signs and symptoms of the index infection, such that no additional antibacterial therapy or surgical or drainage procedure was required for the index infection. (NCT01445678)
Timeframe: EOT; Within 24 hours of last study drug administration
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 and Metronidazole as Treatment for cIAI | 97.1 |
| Meropenem as Treatment for cIAI | 97.5 |
Clinical response is clinical cure at TOC and no signs and symptoms recur or worsen since the TOC visit (NCT01445678)
Timeframe: LFU; 38 to 45 days after first study drug administration
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 and Metronidazole as Treatment for cIAI | 100 |
| Meropenem as Treatment for cIAI | 99.3 |
Clinical response is clinical cure at TOC and no signs and symptoms recur or worsen since the TOC visit. (NCT01445678)
Timeframe: LFU; 38 to 45 days after first study drug administration
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 and Metronidazole as Treatment for cIAI | 82.5 |
| Meropenem as Treatment for cIAI | 86.6 |
Success is eradication (absence of the baseline pathogen in a specimen appropriately obtained from the original site of infection) or presumed eradication (absence of material to culture in a subject who was assessed as a clinical cure) for each baseline pathogen (NCT01445678)
Timeframe: TOC; 26-30 days after start of study drug administration
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 and Metronidazole as Treatment for cIAI | 94.2 |
| Meropenem as Treatment for cIAI | 94.7 |
(NCT01345929)
Timeframe: Test of Cure Visit (7 Days [± 2 days] after completion of study drug administration)
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 as Treatment for cUTI | 76.9 |
| Levofloxacin as Treatment for cUTI | 68.4 |
(NCT01345929)
Timeframe: Test of Cure Visit (7 Days [± 2 days] after completion of study drug administration)
| Intervention | percentage of subjects (Number) |
|---|---|
| CXA-201 as Treatment for cUTI | 83.3 |
| Levofloxacin as Treatment for cUTI | 75.4 |
5 reviews available for metronidazole and Urinary Tract Infections
| Article | Year |
|---|---|
ADVANCES IN OBSTETRICS AND GYNAECOLOGY.
Topics: Anemia; Antineoplastic Agents; Choriocarcinoma; Contraceptive Agents; Contraceptives, Oral; Female; | 1964 |
[Pancreatitis associated with metronidazole].
Topics: Abdominal Injuries; Acute Disease; Adult; Anti-Bacterial Agents; Cervical Vertebrae; Clostridium Inf | 2008 |
Antibacterial prophylaxis--a clinician's view.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Child; Child, Preschool; Female; Hum | 1979 |
Lower genitourinary infections in women.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Cystitis; Diagnosis, Differential; Drug Combinations; F | 1986 |
Animal models for anaerobic infections.
Topics: Animals; Bacteria, Anaerobic; Bacterial Infections; Bacteroides Infections; Disease Models, Animal; | 1985 |
26 trials available for metronidazole and Urinary Tract Infections
| Article | Year |
|---|---|
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Di | 2017 |
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Di | 2017 |
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Di | 2017 |
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Di | 2017 |
Comparison of short versus long term antibiotic prophylaxis in elective caesarean section at the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cesarean Section; Cloxacillin; Drug Admin | 2013 |
Single-dose versus multiple-dose ciprofloxacin plus metronidazole prophylaxis in transrectal ultrasound-guided biopsy of the prostate: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial | 2014 |
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urin | 2017 |
Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbidities.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Cesarean Section; Clo | 2008 |
[Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy].
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Drug Therapy, Combin | 2001 |
Routine use of antimicrobials by pregnant Indian women does not improve birth outcome: a randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Birth Weight; Cephalexin; Female; Genital Diseases, Female; Gestationa | 2005 |
Ampicillin combined with sulbactam or metronidazole for single-dose chemoprophylaxis in major gynaecological surgery.
Topics: Adult; Ampicillin; beta-Lactamase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female | 1984 |
[Healing of the sacral wound cavity after abdomino-perineal extirpation of the rectum. A prospective randomized study using metronidazole].
Topics: Abdomen; Clinical Trials as Topic; Humans; Metronidazole; Perineum; Postoperative Complications; Pro | 1984 |
T-tube suction drainage and/or prophylactic two-dose metronidazole in abdominal hysterectomy.
Topics: Adult; Aged; Bacterial Infections; Clinical Trials as Topic; Dose-Response Relationship, Drug; Femal | 1984 |
Prevention of posthysterectomy infection with a combination of preoperative vaginal and perioperative intravenous administration of metronidazole.
Topics: Adult; Aged; Bacteria, Anaerobic; Bacterial Infections; Female; Humans; Hysterectomy; Infusions, Par | 1983 |
Single and multiple dose cotrimoxazole and metronidazole in colorectal surgery.
Topics: Adult; Aged; Colon; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Metronida | 1980 |
Single dose ceftriaxone versus single dose cefuroxime plus metronidazole for preventing febrile morbidity and urinary tract infection in vaginal hysterectomy.
Topics: Adult; Aged; Aged, 80 and over; Antitrichomonal Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ent | 1995 |
Ceftriaxone is more effective than gentamicin/metronidazole prophylaxis in reducing wound and urinary tract infections after bowel operations. Results of a controlled, randomized, blind clinical trial.
Topics: Aged; Aged, 80 and over; Bacteria; Ceftriaxone; Drug Therapy, Combination; Female; Gentamicins; Huma | 1993 |
Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy.
Topics: Anti-Infective Agents; Bacterial Infections; Double-Blind Method; Female; Humans; Hysterectomy; Infu | 1998 |
Prevention of postcesarean infectious morbidity with a single dose of intravenous metronidazole.
Topics: Adult; Cesarean Section; Endometritis; Female; Humans; Infusions, Intravenous; Metronidazole; Postop | 1991 |
A randomized comparative study of the prophylactic use of trimethoprim-sulfamethoxazole versus netilmycin-metronidazole in transrectal prostatic biopsy.
Topics: Aged; Aged, 80 and over; Biopsy; Drug Combinations; Humans; Infection Control; Infections; Male; Met | 1991 |
Single-dose prophylaxis in hysterectomies. An interim analysis.
Topics: Anti-Bacterial Agents; Cefuroxime; Double-Blind Method; Drug Administration Schedule; Female; Fever; | 1990 |
Vaginal hysterectomy: cefuroxime, metronidazole or both?
Topics: Adult; Aged; Bacterial Infections; Bacteriuria; Body Fluids; Cefuroxime; Double-Blind Method; Drug T | 1990 |
Antibiotic prophylaxis in abdominal hysterectomy, with special reference to the duration of the prophylaxis.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Drug Administration Schedule; Drug Therapy, Combination; F | 1990 |
Antibiotic prophylaxis in vaginal hysterectomy. Three doses of cefuroxime plus metronidazole versus one dose of ciprofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Ciprofloxacin; Drug Administration Schedule; Drug Therap | 1990 |
Prophylaxis in gynaecological surgery: a prospective randomized comparison between single dose prophylaxis with amoxycillin/clavulanate and the combination of cefuroxime and metronidazole.
Topics: Adult; Amoxicillin; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; | 1989 |
Single-shot antibiotic prophylaxis in colon surgery.
Topics: Bacteria; Ceftizoxime; Clinical Trials as Topic; Colonic Neoplasms; Diverticulitis; Humans; Metronid | 1987 |
Single-dose prophylaxis in gynaecological surgery: amoxycillin/clavulanic acid versus the combination of cefuroxim and metronidazole in a randomized prospective comparison.
Topics: Adult; Aged; Amoxicillin; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therap | 1988 |
[Comparative clinical study between Rocephin (Roche) and doxycycline, amoxycillin, erythromycin and amoxycillin + metronidazole combination in gynecology].
Topics: Abscess; Adult; Aged; Amoxicillin; Breast Diseases; Cefotaxime; Ceftriaxone; Clinical Trials as Topi | 1985 |
Metronidazole in the treatment of alcoholism. A clinical trial and review of the literature.
Topics: Adult; Alcohol Drinking; Alcoholism; Clinical Trials as Topic; Humans; Male; Metronidazole; Middle A | 1969 |
39 other studies available for metronidazole and Urinary Tract Infections
| Article | Year |
|---|---|
Reduction in Rates of Symptomatic Urinary Tract Infection After Pelvic Reconstructive Surgery: A Quality Improvement Analysis.
Topics: Cefazolin; Female; Humans; Metronidazole; Pelvic Organ Prolapse; Plastic Surgery Procedures; Postope | 2022 |
Prevalence, Etiology, and Outcome of Sepsis among Critically Ill Patients in Malawi.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Burkholderia Infections; Candida glabra | 2020 |
Prolapse Surgery: What Kind of Antibiotic Prophylaxis Is Necessary?
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Administration Schedule; Female; Gentamici | 2021 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infec | 2017 |
[Metronidazole-induced encephalopathy (MIE)].
Topics: Aged, 80 and over; Anti-Infective Agents; Brain Diseases; Female; Humans; Liver Abscess; Magnetic Re | 2017 |
Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefazolin; Cystectomy; Enter | 2019 |
Pathogenic Sarcina in urine.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Positive Bacterial Infections; | 2016 |
Antibiotic prescribing.
Topics: Anti-Bacterial Agents; Cellulitis; Clindamycin; Clostridioides difficile; Diarrhea; Humans; Medical | 2008 |
Organic psychosis induced by ofloxacin and metronidazole.
Topics: Adolescent; Anti-Infective Agents; Antipsychotic Agents; Citalopram; Drug Therapy, Combination; Fema | 2009 |
Emphysematous pyelonephritis in the setting of diabetes mellitus.
Topics: Anti-Infective Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Emphysema; Escherichia co | 2011 |
Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bulgaria; Clarithromycin; Coinfec | 2012 |
Biodegradable tocopherol acetate as a drug carrier to prevent ureteral stent-associated infection.
Topics: Absorbable Implants; Anti-Infective Agents, Urinary; Bacterial Adhesion; Cross Infection; Drug Carri | 2011 |
[On the treatment of urogenital trichomoniasis in men and women with "Bayer 5360" (Flagyl)].
Topics: Imidazoles; Metronidazole; Trichomonas Infections; Urinary Tract Infections | 1960 |
Flagyl in the treatment of male trichomoniasis.
Topics: Imidazoles; Metronidazole; Trichomonas Infections; Urinary Tract Infections | 1961 |
Urogenital trichomoniasis in the male: review of the literature and report on treatment of 37 patients by a new nitroimidazole derivative (Flagyl).
Topics: Imidazoles; Metronidazole; Nitroimidazoles; Trichomonas Infections; Urinary Tract Infections | 1960 |
THERAPEUTIC PROBLEMS IN URINARY INFECTIONS.
Topics: Chloramphenicol; Enterobacter aerogenes; Escherichia coli Infections; Humans; Hydrocortisone; Imidaz | 1964 |
CURRENT THERAPY OF INFECTIONS OF THE RENAL EXCRETORY SYSTEM.
Topics: Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Azo Compounds; Bacitracin; Chlormerodr | 1964 |
[Treatment of urogenital trichomoniasis with metronidazole (Flagyl)].
Topics: Communicable Diseases; Imidazoles; Infections; Metronidazole; Trichomonas Infections; Urinary Tract | 1962 |
Trichomonas vaginalis urinary infection in a boy.
Topics: Child; Humans; Male; Metronidazole; Trichomonas Infections; Urinary Tract Infections | 1967 |
Prophylactic metronidazole or suction drainage in abdominal hysterectomy.
Topics: Adult; Aged; Bacterial Infections; Female; Fever; Humans; Hysterectomy; Metronidazole; Middle Aged; | 1984 |
Double-blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy.
Topics: Double-Blind Method; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Infusions, Parenteral; Len | 1983 |
Metronidazole in the prophylaxis of anaerobic infections in gynecologic surgery.
Topics: Cesarean Section; Double-Blind Method; Female; Humans; Hysterectomy; Metronidazole; Pregnancy; Preme | 1983 |
[Metronidazole prophylaxis for vaginal hysterectomy (author's transl)].
Topics: Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Length of Stay; Metronidazole; Prospective Stud | 1982 |
Cefuroxime and metronidazole in gynaecological surgery.
Topics: Bacteria; Cefuroxime; Cephalosporins; Female; Genitalia, Female; Humans; Metronidazole; Postoperativ | 1981 |
Pseudomembranous colitis in a patient with a colostomy.
Topics: Cephalexin; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Mi | 1995 |
Postoperative urinary tract infections (UTIs) following single-dose intraoperative antibiotic prophylaxis in colposuspension patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxi | 1998 |
Trichomonas vaginalis in a perinephric abscess. A case report.
Topics: Abscess; Chronic Disease; Cystitis; Female; Humans; Metronidazole; Middle Aged; Perinephritis; Trich | 1975 |
Aminoglycosides in gynecologic infections.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clindamycin; | 1986 |
Metronidazole-quinolone combination: antibacterial activity in vitro.
Topics: Bacteria; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Quinolines; Urinary Tr | 1985 |
Vaginitis in adolescent girls.
Topics: Adolescent; Boric Acids; Candida; Candidiasis, Vulvovaginal; Child; Enterobius; Female; Foreign Bodi | 1971 |
Ways and means for obtaining stable results in the treatment of genito-urinary trichomonadosis.
Topics: Drug Resistance; Estonia; Female; Humans; Male; Metronidazole; Prognosis; Trichomonas Infections; Tr | 1973 |
Practical aspects of anaerobic sepsis.
Topics: Abscess; Anaerobiosis; Arthritis, Infectious; Bacterial Infections; Bacteroides; Bone Diseases; Brai | 1973 |
[Studies on Trichomonas vaginalis in urological field. VI. Clinical efficacy of various drugs].
Topics: Adult; Antifungal Agents; Female; Humans; Male; Metronidazole; Nitrofurans; Nitrofurantoin; Prostati | 1973 |
Fresh drugs for old problems.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Azathioprine; Cephalosporins; Humans; Liver Abscess, | 1971 |
["Urinary tract infection" in women caused by gonococci].
Topics: Adolescent; Adult; Diagnosis, Differential; Female; Gonorrhea; Humans; Metronidazole; Urinary Tract | 1970 |
[Trichonomas vaginalis found outside the vagina].
Topics: Female; Humans; Male; Metronidazole; Middle Aged; Trichomonas Infections; Urinary Tract Infections | 1968 |
Erythema multiforme bullosum associated with Trichomonas infection.
Topics: Erythema Multiforme; Female; Humans; Metronidazole; Middle Aged; Trichomonas Infections; Urinary Tra | 1965 |
Urinary tract infection by Trichomonas vaginalis in a newborn baby.
Topics: Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Metronidazole; Trichomonas Infections; U | 1966 |
[Trichomoniasis urogenitalis and metronidazol therapy in dermato-venerologic practice].
Topics: Adult; Female; Humans; Male; Metronidazole; Trichomonas Infections; Urinary Tract Infections; Urolog | 1966 |